Clinical Trial of A Low Dose Combined Oral Contraceptive (‘Ovranette’)
- 1 January 1975
- journal article
- clinical trial
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 3 (2), 72-76
- https://doi.org/10.1185/03007997509113650
Abstract
SummaryA combination of 150 µg. d-norgestrel with 30 µg. ethinyl oestradiol was administered to 120 women for a total of '767 cycles. No pregnancies occurred and cycle control was good, 99% of the cycles being within the range of 28.3 days. Breakthrough bleeding occurred in 7.2 % of the cycles, spotting in 8.9 % and amenorrhoea in 0.8 %. Side-effects were minimal.Keywords
This publication has 7 references indexed in Scilit:
- A new low-oestrogen, low-progestogen combined oral contraceptiveCurrent Medical Research and Opinion, 1974
- Clinical assessment of a low-dose oestrogen, low-dose progestogen combined oral contraceptive.Current Medical Research and Opinion, 1974
- Clinical Assessment of Low Oestrogen Combined Oral ContraceptiveBMJ, 1973
- A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptivesContraception, 1972
- Nervousness and depression attributed to oral contraceptives: A double-blind, placebo-controlled studyAmerican Journal of Obstetrics and Gynecology, 1971
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- EVALUATION OF RARE ADVERSE EFFECTS OF SYSTEMIC CONTRACEPTIVESBritish Medical Bulletin, 1970